Old names:
Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Scannell Robert | 0001604257 | Nov-17-2015 | director |
McMahon William L | 0001359663 | Aug-14-2015 | officer: CFO and Treasurer |
SAMUEL SUNITHA CHUNDRU | 0001640062 | Apr-20-2015 | director |
CANAAN LEE M | 0001134252 | Aug-01-2014 | director |
McDONNELL EDWARD J. | 0001617930 | Aug-01-2014 | director |
Tradewinds Capital, L.P. | 0001548550 | Apr-02-2014 | other: See Remarks |
Tradewinds Fund (Cayman), Ltd. | 0001548551 | Apr-02-2014 | 10 percent owner |
Dent Benjamin M | 0001594991 | Dec-27-2013 | director |
Sensenbrenner Scott P | 0001595167 | Dec-27-2013 | director |
Mullan Michael J | 0001595196 | Dec-27-2013 | director, officer: Chief Executive Officer |
Whittel Naomi | 0001595263 | Dec-27-2013 | director |
Wilson Thomas L | 0001595266 | Dec-27-2013 | director |
PERITO PAUL L | 0001087905 | Dec-24-2013 | director, officer: President & COO |
EVERETT RALPH B | 0001243427 | Dec-14-2013 | director |
Haynes Burton J. | 0001504151 | Oct-22-2013 | director |
Chapman Christopher C JR | 0001340428 | Sep-22-2013 | director |
Chayet Neil L | 0001412566 | Sep-07-2013 | director |
POKUSA ROBERT E | 0001280485 | Apr-05-2012 | officer: General Counsel |
DEAN DAVID MICHAEL | 0001301584 | Apr-05-2012 | officer: V.P. Sales & Marketing |
Dodd Park A III | 0001414533 | Apr-05-2012 | officer: Chief Financial Officer |
Wright Curtis IV | 0001429992 | Apr-05-2012 | officer: Senior Vice President |
Mirabelli Mario V. | 0001497622 | Apr-05-2012 | director |
WILLIAMS JONNIE | 0001056017 | Dec-31-2011 | director, 10 percent owner, officer: CEO |
SHARP RICHARD L | 0000939448 | Mar-17-2011 | director |
Peters Scott | 0001444109 | Sep-14-2008 | other: Less than 10% owner |
Feehan Partners, L.P. | 0001445823 | Sep-14-2008 | other: Less than 10% owner |
P.V. Partners, L.P. | 0001445824 | Sep-14-2008 | other: Less than 10% owner |
Tradewinds Master Fund (BVI) Ltd. | 0001445825 | Sep-14-2008 | other: Less than 10% owner |
Weichelbaum Alan | 0001412577 | Sep-07-2007 | director |
OKEN MARC D | 0001189900 | Oct-11-2005 | director |
Vorhoff David C | 0001342020 | Oct-11-2005 | director |
Carmen Gerald Posner | 0001319042 | Sep-22-2005 | director |
MILLER CHRISTOPHER G | 0001248332 | Apr-21-2005 | officer: Chief Financial Officer |
KELLEY WHITMORE B | 0001248329 | Apr-13-2004 | director |
BARTELS JOHN R | 0001248326 | Jan-28-2004 | director |
TONKIN LEO S | 0001073828 | Nov-20-2003 | director |
ODONNELL KATHLEEN M TR IRREV TR 1 FBO FRANCIS E ODONNELL JR | 0001262022 | Aug-18-2003 | 10 percent owner |
LAMB PAUL H III | 0000905598 | Dec-11-1998 | officer: Pres. of Star Tobacco, Inc. |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ROCK CREEK PHARMACEUTICALS, INC.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
REVOKED | Document | Acc-no: 9999999997-23-000566 (34 Act) Size: 476 KB | Feb-14-2023 | 23623663 |
8-K | Document | Current report filing Acc-no: 0001144204-16-125682 (34 Act) Size: 16 KB |
Sep-28-2016 | 161906062 |
8-K | Document | Current report filing Acc-no: 0001144204-16-121799 (34 Act) Size: 17 KB |
Aug-29-2016 | 161858503 |
8-K | Document | Current report filing Acc-no: 0001144204-16-119927 (34 Act) Size: 25 KB |
Aug-17-2016 | 161837794 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-16-118075 (34 Act) Size: 2419 KB |
Aug-10-2016 | 161822156 |
DEF 14A | Document | Definitive proxy statements Acc-no: 0001144204-16-114030 (34 Act) Size: 922 KB |
Jul-22-2016 | 161778537 |
PRE 14A | Document | Preliminary proxy statement not related to a contested matter or merger/acquisition Acc-no: 0001144204-16-112442 (34 Act) Size: 926 KB |
Jul-11-2016 | 161762588 |
8-K | Document | Current report filing Acc-no: 0001144204-16-112269 (34 Act) Size: 15 KB |
Jul-08-2016 | 161759957 |
8-K | Document | Current report filing Acc-no: 0001144204-16-112109 (34 Act) Size: 57 KB |
Jul-08-2016 | 161757666 |
DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0001144204-16-112110 (34 Act) Size: 57 KB |
Jul-08-2016 | 161757662 |
8-K | Document | Current report filing Acc-no: 0001144204-16-102768 (34 Act) Size: 5330 KB |
May-16-2016 | 161654989 |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001144204-16-102758 (33 Act) Size: 80 KB |
May-16-2016 | 161654935 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-16-102745 (34 Act) Size: 2237 KB |
May-16-2016 | 161654884 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001144204-16-097947 (33 Act) Size: 258 KB |
Apr-29-2016 | 161608587 |
10-K/A | Document | Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001144204-16-097796 (34 Act) Size: 253 KB |
Apr-29-2016 | 161606585 |
D | Document | Acc-no: 0000897069-16-000799 (33 Act) Size: 10 KB | Apr-13-2016 | 161568683 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001144204-16-093015 (33 Act) Size: 382 KB |
Apr-06-2016 | 161558103 |
8-K | Document | Current report filing Acc-no: 0001144204-16-092819 (34 Act) Size: 235 KB |
Apr-05-2016 | 161555256 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001140361-16-059675 ( Act) Size: 14 KB |
Mar-31-2016 | |
8-K | Document | Current report filing Acc-no: 0001144204-16-091760 (34 Act) Size: 146 KB |
Mar-31-2016 | 161541727 |
Recent 20 filings. View all ROCK CREEK PHARMACEUTICALS, INC. filings
Huge help thank you for your help .. y'all make it so much easier
Thanks I look forward to using the product to improve my skin tone
Very good communication and delivery made within the timeframe I was advised of
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by